90 related articles for article (PubMed ID: 18692709)
1. Premenstrual syndrome.
Helmerhorst FM; Lopez LM; Kaptein AA
Lancet; 2008 Aug; 372(9637):446; author reply 446-7. PubMed ID: 18692709
[No Abstract] [Full Text] [Related]
2. Hormonal contraceptives for acne management.
Rich P
Cutis; 2008 Jan; 81(1 Suppl):13-8. PubMed ID: 18338653
[TBL] [Abstract][Full Text] [Related]
3. The new extended regimen for the management of premenstrual symptoms needs to be properly assessed.
Marasinghe JP; Don CK; Amarasinghe AA
Am J Obstet Gynecol; 2007 Oct; 197(4):436; author reply 436-7. PubMed ID: 17904994
[No Abstract] [Full Text] [Related]
4. [The position of drospirenone in premenstrual syndrome teratment].
Havlín M
Ceska Gynekol; 2006 Jan; 71(1):70, 72-3. PubMed ID: 16465920
[TBL] [Abstract][Full Text] [Related]
5. A new monophasic oral contraceptive containing drospirenone. Effect on premenstrual symptoms.
Brown C; Ling F; Wan J
J Reprod Med; 2002 Jan; 47(1):14-22. PubMed ID: 11838304
[TBL] [Abstract][Full Text] [Related]
6. [Jangee – young, free and beautiful].
Velev P
Akush Ginekol (Sofiia); 2012; 51 Suppl 1():47. PubMed ID: 23236681
[No Abstract] [Full Text] [Related]
7. [Extracontraceptive benefits of EE/DRSP (Yaz) in 24+4 day regimen].
Bruni Bresciani V
Minerva Ginecol; 2010 Jun; 62(3):261-6. PubMed ID: 20595950
[TBL] [Abstract][Full Text] [Related]
8. Quality of life issues. Potential role for an oral contraceptive containing ethinyl estradiol and drospirenone.
Dickerson V
J Reprod Med; 2002 Nov; 47(11 Suppl):985-93. PubMed ID: 12497673
[TBL] [Abstract][Full Text] [Related]
9. Comparison of scales for evaluating premenstrual symptoms in women using oral contraceptives.
Coffee AL; Kuehl TJ; Sulak PJ
Pharmacotherapy; 2008 May; 28(5):576-83. PubMed ID: 18447656
[TBL] [Abstract][Full Text] [Related]
10. Drospirenone, a progestogen with antimineralocorticoid properties: a short review.
Oelkers W
Mol Cell Endocrinol; 2004 Mar; 217(1-2):255-61. PubMed ID: 15134826
[TBL] [Abstract][Full Text] [Related]
11. Oral contraceptives and premenstrual symptoms: comparison of a 21/7 and extended regimen.
Coffee AL; Kuehl TJ; Willis S; Sulak PJ
Am J Obstet Gynecol; 2006 Nov; 195(5):1311-9. PubMed ID: 16796986
[TBL] [Abstract][Full Text] [Related]
12. An oral contraceptive with 3 approved indications.
Mishell DR
J Reprod Med; 2008 Sep; 53(9 Suppl):717-9. PubMed ID: 18980043
[No Abstract] [Full Text] [Related]
13. Evaluation of a unique oral contraceptive (Yasmin) in the management of premenstrual dysphoric disorder.
Freeman EW
Eur J Contracept Reprod Health Care; 2002 Dec; 7 Suppl 3():27-34; discussion 42-3. PubMed ID: 12659404
[TBL] [Abstract][Full Text] [Related]
14. Superiority of a combined contraceptive containing drospirenone to a triphasic preparation containing norgestimate in acne treatment.
Thorneycroft lH; Gollnick H; Schellschmidt I
Cutis; 2004 Aug; 74(2):123-30. PubMed ID: 15379365
[TBL] [Abstract][Full Text] [Related]
15. The state of hormonal contraception today: established and emerging noncontraceptive health benefits.
Maguire K; Westhoff C
Am J Obstet Gynecol; 2011 Oct; 205(4 Suppl):S4-8. PubMed ID: 21961824
[TBL] [Abstract][Full Text] [Related]
16. Ovulation suppression of premenstrual symptoms using oral contraceptives.
Sulak PJ
Am J Manag Care; 2005 Dec; 11(16 Suppl):S492-7. PubMed ID: 16336058
[TBL] [Abstract][Full Text] [Related]
17. A comparative study of monophasic oral contraceptives containing either drospirenone 3 mg or levonorgestrel 150 microg on premenstrual symptoms.
Sangthawan M; Taneepanichskul S
Contraception; 2005 Jan; 71(1):1-7. PubMed ID: 15639064
[TBL] [Abstract][Full Text] [Related]
18. [Therapy of heart failure after myocardial infarction. With eplerenone a new course].
MMW Fortschr Med; 2004 Oct; 146(43):58-9. PubMed ID: 15559524
[No Abstract] [Full Text] [Related]
19. Efficacy of a new low-dose oral contraceptive with drospirenone in premenstrual dysphoric disorder.
Yonkers KA; Brown C; Pearlstein TB; Foegh M; Sampson-Landers C; Rapkin A
Obstet Gynecol; 2005 Sep; 106(3):492-501. PubMed ID: 16135578
[TBL] [Abstract][Full Text] [Related]
20. A new hormone therapy with drospirenone and NO production in postmenopausal women.
Tsuda K
Hypertension; 2006 Nov; 48(5):e106; author reply e107. PubMed ID: 17000926
[No Abstract] [Full Text] [Related]
[Next] [New Search]
